Wegovy UK Private: the evidence, the eligibility, and how to access it

What the trial data actually says about private semaglutide for weight loss

The case for Wegovy is built on STEP 1, a 68-week trial involving around 1,900 adults with obesity who did not have type 2 diabetes. Participants receiving weekly semaglutide 2.4mg alongside lifestyle support lost roughly 15% of body weight on average, compared with about 2.4% on placebo. Those figures, published in the New England Journal of Medicine, are the numbers any honest provider should be quoting.

Since those results were published, Novo Nordisk completed clinical work on a higher maintenance dose. In April 2026 the MHRA approved a dedicated 7.2mg single-dose pen, with trials reporting around 20.7% average weight loss over 72 weeks, approaching the results seen with tirzepatide 15mg. If you're exploring private semaglutide treatment and wondering which medicine or dose might suit you, that's a conversation that belongs with a prescriber, not a website.

One practical note worth making here: results in trials are averages across large, diverse populations. Individual outcomes depend on starting weight, adherence, diet, activity and how well the dose is tolerated. No legitimate provider should promise you the headline figure personally.

Who qualifies for private Wegovy in the UK, and how that differs from the NHS route

The medicine's licence sets the floor for private eligibility. Wegovy is approved for adults with a BMI of 30 or above, or 27 to 29.9 with at least one weight-related condition, high blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnoea or cardiovascular disease. Lower BMI thresholds apply for people from some South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, in line with UK clinical guidance.

The NHS route for Wegovy, governed by NICE's appraisal TA875, adds further restrictions: treatment must be delivered within a specialist weight management service, for a maximum of two years, and criteria are tighter than the licence alone. Many people who are eligible on medical grounds do not currently qualify under the NHS pathway, or face waits that make private treatment a practical decision rather than a luxury one.

Going private lifts the specialist-service requirement and the two-year cap, you're treated under the medicine's licence, assessed by a registered prescriber. It does not, however, lift the requirement for clinical assessment. Getting Wegovy privately still means a prescriber reviewing your health history, current medicines and circumstances before writing any prescription.

What a safe, legitimate private Wegovy supply looks like

The MHRA has been explicit on this: Wegovy is a prescription-only medicine and should only be obtained following a proper clinical assessment. Counterfeit and unregulated weight-loss pens are a documented problem, the MHRA has published guidance on reporting suspect sellers, and enforcement operations in 2024 and 2025 seized large quantities of fake product, some of it dangerous. Sellers offering these medicines without a clinical review, or via social media with prices far below the market, are a serious red flag.

The minimum you should verify before using any private provider: check they hold a GPhC pharmacy registration. It takes under a minute, visit the GPhC pharmacy register, search the name or registration number, and confirm the premises entry is live and current. That single check rules out a substantial proportion of illegitimate sellers.

You might also want to read about what Wegovy costs privately to understand the typical market range, because prices far below it are worth treating with scepticism. A legitimate price reflects consultation, prescription, dispensing, and dispensary overheads, not just the pen.

How private Wegovy access works at a GPhC-registered pharmacy

At a regulated online pharmacy, the journey for private Wegovy follows a clear sequence. You complete a clinical questionnaire, covering health history, current medicines, weight, and any relevant conditions. A GPhC-registered Independent Prescriber, a real clinician, reviews those answers before anything is dispensed. Identity and weight are verified. If the treatment is appropriate, a prescription is written and the medicine is dispensed from a GPhC-registered pharmacy.

At nume, that prescriber review happens the same day. Orders placed before noon on a working day are dispatched the same day once approved, arriving the next working day via tracked DPD delivery. There is no subscription, no auto-renewal and no hidden charge: the private Wegovy prescription covers consultation, prescription and delivery in a single transparent price shown on the treatment page.

For anyone weighing up whether this route makes sense, the private clinic vs online pharmacy comparison is worth reading. And if you already have questions, the nume FAQ page covers the most common ones. When you're ready, speak to our prescribers for a free same-day consultation, no obligation, no commitment before approval.